Evidence map›Paper›PMID 27922451›Full record

ArticleeLife2016

Direct screening for chromatin status on DNA barcodes in yeast delineates the regulome of H3K79 methylation by Dot1.

Hanneke Vlaming, Thom M Molenaar, Tibor van Welsem, Deepani W Poramba-Liyanage, Desiree E Smith, Arno Velds, Liesbeth Hoekman, Tessy Korthout, Sjoerd Hendriks, A F Maarten Altelaar and 1 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Hanneke VlamingDivision of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands.ORCID 0000-0003-1743-6428
Thom M MolenaarDivision of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands.
Tibor van WelsemDivision of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands.
Deepani W Poramba-LiyanageDivision of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands.
Desiree E SmithDepartment of Clinical Chemistry, Metabolic Laboratory, VU University Medical Center, Amsterdam, Netherlands.
Arno VeldsCentral Genomics Facility, Netherlands Cancer Institute, Amsterdam, Netherlands.
Liesbeth HoekmanMass Spectrometry/Proteomics Facility, Netherlands Cancer Institute, Amsterdam, Netherlands.
Tessy KorthoutDivision of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands.
Sjoerd HendriksDivision of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands.
A F Maarten AltelaarMass Spectrometry/Proteomics Facility, Netherlands Cancer Institute, Amsterdam, Netherlands.
Fred van LeeuwenDivision of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands.ORCID 0000-0002-7267-7251
The Netherlands Cancer Institute · NLAmsterdam UMC Location Vrije Universiteit Amsterdam · NLCancer Genomics Centre · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given the frequent misregulation of chromatin in cancer, it is important to understand the cellular mechanisms that regulate chromatin structure. However, systematic screening for epigenetic regulators is challenging and often relies on laborious assays or indirect reporter read-outs. Here we describe a strategy, Epi-ID, to directly assess chromatin status in thousands of mutants. In Epi-ID, chromatin status on DNA barcodes is interrogated by chromatin immunoprecipitation followed by deep sequencing, allowing for quantitative comparison of many mutants in parallel. Screening of a barcoded yeast knock-out collection for regulators of histone H3K79 methylation by Dot1 identified all known regulators as well as novel players and processes. These include histone deposition, homologous recombination, and adenosine kinase, which influences the methionine cycle. Gcn5, the acetyltransferase within the SAGA complex, was found to regulate histone methylation and H2B ubiquitination. The concept of Epi-ID is widely applicable and can be readily applied to other chromatin features.

Indexed as

Gene Expression Regulation, FungalProtein Processing, Post-TranslationalChromatinChromatin ImmunoprecipitationDNA, FungalGenetics, MicrobialGenetic TestingHistone-Lysine N-MethyltransferaseHistonesMethylationMolecular BiologyNuclear ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSequence Analysis, DNAChromatinDNA, FungalDot1 protein, S cerevisiaeHistone-Lysine N-MethyltransferaseHistonesNuclear ProteinsSaccharomyces cerevisiae Proteinsadenosine kinasechromosomesDNA repairDot1genesH3K79 methylationhistone modificationsSAGAS. cerevisiae

Identifiers

PMID27922451
PMCPMC5179194
OpenAlexW2560262788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.